Tenon Medical, Inc.
TNON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.01 | -0.00 |
| FCF Yield | -440.95% | -437.18% | -100.83% | -21.63% |
| EV / EBITDA | 0.29 | -0.15 | -0.63 | -5.05 |
| Quality | ||||
| ROIC | -166.64% | -339.38% | -213.10% | -83.84% |
| Gross Margin | 52.21% | 42.38% | -92.76% | 65.63% |
| Cash Conversion Ratio | 0.72 | 0.78 | 0.64 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 68.01% | 163.52% | 150.77% | 43.95% |
| Free Cash Flow Growth | 19.77% | 2.55% | -192.94% | -2,525.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.47 | 0.04 | 0.07 | -1.84 |
| Interest Coverage | -404.88 | -748.90 | -52.90 | -10.40 |
| Efficiency | ||||
| Inventory Turnover | 2.58 | 3.05 | 3.21 | 0.29 |
| Cash Conversion Cycle | 151.36 | 91.75 | 90.31 | -1,751.17 |